Decoction medicine for treating early-stage cervical cancer and preparation method thereof

Abstract

The invention belongs to the field of traditional Chinese medicine preparation and aims to provide a decoction medicine for treating early-stage cervical cancer according to the understanding mechanism for treating early-stage cervical cancer by using traditional Chinese medicines. The decoction medicine is prepared from the following components in parts by mass: 6-15g of radix angelicae sinensis,5-15g of safflower, 2-6g of leech, 4-12g of radix paeoniae rubra, 8-16g of radix salviae miltiorrhizae, 2.5-5g of gadfly, 2-6g of rhizoma coptidis, 9-35g of rhizoma dioscoreae, 3-12g of radix bupleuri, 3-12g of radix curcumae, 5-12g of rhizoma cyperi, 9-16g of radix scrophulariae, 5-16g of radix achyranthis bidentatae, 6-16g of fructus forsythia, 6-15g of rhizoma anemarrhenae, 3-9g of airpotato yam rhizome, 15-35g of radix ranunculi ternati, 6-16g of spica prunellae, 5-10g of eupolyphoge sinensis, 5-12g of rhizoma sparganii, 15-50g of semen coicis and 9-35g of ormosia. The decoction medicineis an excellent traditional Chinese medicine formula.

Description

technical field [0001] The invention belongs to the field of traditional Chinese medicine preparations, in particular to a decoction medicine for treating early cervical cancer, in particular to the field of decoction medicine for patients with early cervical cancer and a preparation method thereof. Background technique [0002] Motherland medicine believes that: cervical cancer refers to malignant tumors that occur at the junction of squamous epithelial cells of the cervicovaginal or transition zone and columnar epithelial cells of the endocervical endometrium. Cervical cancer is the most common tumor in the female reproductive system. Malignant tumor, its clinical manifestations are: menstruation or excessive leucorrhea, irregular vaginal bleeding, waist and abdomen pain, anemia, weight loss and other systemic debilitating symptoms. [0003] In recent years, the incidence of cervical cancer has been on the rise, and the incidence of cervical cancer is gradually becoming yo...

AI Technical Summary

Problems solved by technology

The long-term clinical point of view is that the sensitivity of chemotherapy for cervical cancer is poor, and the effective rate is lower than about 15%. Currently, chemotherapy drugs for cervical cancer can be injected intravenously or locally with 5-fluorouracil, doxorubicin, etc. Doxorubicin has a severe toxic reaction and has been found to be carcinogenic in animal experiments. There are potential carcinogens in the human body, which have a great impact on reproductive function

The current surgical plan is to remove cancerous tissue and undergo chemotherapy and radiotherapy, which is extremely harmful to women's bodies.